Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 26, 2026

NatWest cuts mortgage costs ahead of spring statement

View original at uk.finance.yahoo.com
NatWest cuts mortgage costs ahead of spring statement NatWest has cut borrowing costs this week as most lenders adopted a wait-and-see approach ahead of the spring statement that is due on 3 March…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • It marks the lowest reading for the Consumer Price Index since March last year

    80% confidence

  • It is widely expected that no major housing reforms will be announced in Rachel Reeves's statement

    80% confidence

  • The change was part of a reprice following the changes to swaps after the Bank of England held interest rates

    80% confidence

  • Average five-year fixed deal came in at 4.99%, up from the previous 4.94%

    80% confidence

  • Consumer prices rose 3% in the year to January, down from 3.4% in December

    80% confidence

  • Average rate for two-year fixed mortgage came in at 4.75% this week, higher than last week's 4.53%

    80% confidence

  • Financial markets are pricing in a 0.25 percentage point reduction in the Bank of England's base rate to 3.5% at its meeting on 19 March

    80% confidence

Data points we hold from this source

Barclays · five year fixed mortgage rate4.00 percent
Barclays · two year fixed mortgage rate3.70 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
NatWest cuts mortgage costs ahead of spring statement — Source | Via News | ViaNews Market